用酰胺水解法测定肝素辅因子活性。 - Suppr

Heparin cofactor activity measured with an amidolytic method.

作者信息

Odegard O R, Lie M, Abildgaard U

出版信息

Thromb Res. 1975 Apr;6(4):287-94. doi: 10.1016/0049-3848(75)90078-x.

DOI:10.1016/0049-3848(75)90078-x

PMID:49087

Abstract

摘要

相似文献

Heparin cofactor activity measured with an amidolytic method.

Thromb Res. 1975 Apr;6(4):287-94. doi: 10.1016/0049-3848(75)90078-x.

Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.

Thromb Res. 1975 Jan;6(1):27-38. doi: 10.1016/0049-3848(75)90148-6.

A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.

Thromb Res. 1976 Jun;8(6):745-56. doi: 10.1016/0049-3848(76)90003-7.

Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.

Am J Clin Pathol. 1976 Sep;66(3):488-94. doi: 10.1093/ajcp/66.3.488.

Letter: DIC-fibrinolysis with low antithrombin-heparin cofactor.

N Engl J Med. 1975 Apr 10;292(15):810. doi: 10.1056/NEJM197504102921517.

Evaluation of an amidolytic heparin cofactor assay method.

Thromb Res. 1975 Aug;7(2):351-60. doi: 10.1016/0049-3848(75)90193-0.

Antithrombin III, heparin cofactor and antifactor Xa in a clinical material.

Thromb Res. 1976 Feb;8(2):173-8. doi: 10.1016/0049-3848(76)90260-7.

Actions and interactions of antithrombin and heparin.

N Engl J Med. 1975 Jan 16;292(3):146-51. doi: 10.1056/NEJM197501162920307.

[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].

Nihon Rinsho. 2004 Dec;62 Suppl 12:626-8.

Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?

Am J Gastroenterol. 1999 Oct;94(10):2977-82. doi: 10.1111/j.1572-0241.1999.01446.x.

引用本文的文献

Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: A prospective population-based study.

Br J Haematol. 2025 Feb;206(2):657-665. doi: 10.1111/bjh.19999. Epub 2025 Jan 19.

Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Thromb Res. 2021 May;201:50-59. doi: 10.1016/j.thromres.2021.02.007. Epub 2021 Feb 16.

Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.

J Thromb Thrombolysis. 2019 Feb;47(2):216-226. doi: 10.1007/s11239-018-1762-7.

Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.

J Thromb Thrombolysis. 2018 Aug;46(2):154-165. doi: 10.1007/s11239-018-1662-x.

Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Gene. 2018 Mar 20;647:136-142. doi: 10.1016/j.gene.2018.01.013. Epub 2018 Jan 9.

Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.

J Thromb Thrombolysis. 2017 Jul;44(1):130-138. doi: 10.1007/s11239-017-1491-3.

Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.

J Thromb Thrombolysis. 2016 Jul;42(1):135-41. doi: 10.1007/s11239-015-1328-x.

Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

J Am Soc Nephrol. 2015 Dec;26(12):3009-19. doi: 10.1681/ASN.2014111097. Epub 2015 Apr 8.

[Heparin resistance and antithrombin deficiency].

Med Klin (Munich). 2009 Jun 15;104(6):441-9. doi: 10.1007/s00063-009-1093-8. Epub 2009 Jun 16.

Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.

Am J Pathol. 2002 May;160(5):1867-75. doi: 10.1016/S0002-9440(10)61133-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Heparin cofactor activity measured with an amidolytic method.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献